Publications by authors named "Christopher D Nishimura"

Claim this Profile
T
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors.
Christopher D Nishimura, Devin Corrigan, Xiang Yu Zheng, Phillip M Galbo, Shan Wang

Sci Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells.
Hao Wang, R Alejandro Sica, Gurbakhash Kaur, Phillip M Galbo, Zhixin Jing, Christopher D Nishimura

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression.
Yu Liu, Peter John, Kenta Nishitani, Jihong Cui, Christopher D Nishimura

Dev Cell· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies.
Christopher D Nishimura, Marc C Pulanco, Wei Cui, Liming Lu, Xingxing Zang

Trends Mol Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals.
Christopher D Nishimura, Daniel A Brenner, Malini Mukherjee, Rachel A Hirsch, Leah Ott

Blood· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis